A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma

被引：0
|
作者：
Shain, Kenneth H. [1 ]
Silva, Ariosto [2 ]
Meads, Mark B. [3 ]
Distler, Allison [3 ]
Jacobson, Timothy [2 ]
Gatenby, Robert [2 ]
Baz, Rachid [1 ]
Silva, Maria [4 ]
Rebatchouk, Dmitri [5 ]
Cubitt, Chris [4 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Intergrated Math Oncol, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] nPharmakon, Piscataway, NJ USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
    Bhatt, Parva
    Kloock, Colin
    Comenzo, Raymond
    CURRENT ONCOLOGY, 2023, 30 (02) : 2322 - 2347
  • [42] Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
    Kfir-Erenfeld, Shlomit
    Asherie, Nathalie
    Lebel, Eyal
    Vainstein, Vladimir
    Assayag, Miri
    Sharon, Tatyana Dubnikov
    Grisariu, Sigal
    Avni, Batia
    Elias, Shlomo
    Alexander-Shani, Rivka
    Bessig, Nomi
    Shehadeh, Alaa
    Ishtay, Aseel
    Zelmanovich, Veronica
    Zimran, Eran
    Pick, Marjorie
    Roziner, Ilan
    Kenett, Ron S.
    Cohen, Yael
    Avivi, Irit
    Cohen, Cyrille J.
    Gatt, Moshe E.
    Stepensky, Polina
    BLOOD ADVANCES, 2024, 8 (15) : 4077 - 4088
  • [43] US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
    Bassali, Jan
    Gould, Ian Gopal
    Kaye, James A.
    Mladsi, Deirdre
    Mehta, Jyotsna
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 317 - 325
  • [44] Duration of Treatment of Multiple Myeloma Regimens in Patients with Relapsed or Refractory Multiple Myeloma: Findings in US Clinical Practice Settings
    Potluri, Ravi
    Kanakamedala, Hemanth
    Chen, Clara
    Yasenchak, Christopher A.
    Ranjan, Sandip
    Papademetriou, Eros
    Bhandari, Hitesh
    Mann, Jasdeep
    Davis, Catherine
    BLOOD, 2017, 130
  • [45] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Moreau, Philippe
    Garfall, Alfred L.
    van de Donk, Niels W. C. J.
    Nahi, Hareth
    San-Miguel, Jesus F.
    Oriol, Albert
    Nooka, Ajay K.
    Martin, Thomas
    Rosinol, Laura
    Chari, Ajai
    Karlin, Lionel
    Benboubker, Lotfi
    Mateos, Maria-Victoria
    Bahlis, Nizar
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Sidana, Surbhi
    Delforge, Michel
    Pei, Lixia
    Trancucci, Danielle
    Verona, Raluca
    Girgis, Suzette
    Lin, Shun X. W.
    Olyslager, Yunsi
    Jaffe, Mindy
    Uhlar, Clarissa
    Stephenson, Tara
    Van Rampelbergh, Rian
    Banerjee, Arnob
    Goldberg, Jenna D.
    Kobos, Rachel
    Krishnan, Amrita
    Usmani, Saad Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
  • [46] APPROACH IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Delforge, Michel
    LEUKEMIA RESEARCH, 2014, 38 : S14 - S14
  • [47] Pomalidomide in the treatment of relapsed multiple myeloma
    Forsberg, Peter A.
    Mark, Tomer M.
    FUTURE ONCOLOGY, 2013, 9 (07) : 939 - 948
  • [48] Cutaneous involvement in relapsed multiple myeloma
    Salle, Valery
    Attencourt, Christophe
    Chevalier, Marion
    Semeria, Lucile
    Boulu, Xavier
    Karam, Jean-Denis
    Smail, Amar
    Schmidt, Jean
    Duhaut, Pierre
    Dernoncourt, Amandine
    CLINICAL CASE REPORTS, 2022, 10 (09):
  • [49] Treatment of relapsed and refractory multiple myeloma
    Engelhardt, M.
    Graziani, G.
    Javorniczky, R.
    Neubauer, J.
    Koehler, M.
    Herget, G. W.
    Waesch, R.
    ONKOLOGE, 2018, 24 (08): : 613 - 624
  • [50] Thalidomide in the treatment of relapsed multiple myeloma
    Rajkumar, SV
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Lust, JA
    Witzig, TE
    Kyle, RA
    Gertz, MA
    Greipp, PR
    MAYO CLINIC PROCEEDINGS, 2000, 75 (09) : 897 - 901
12345